Condition: Liver Cancer Adult · Liver Regeneration · Sponsor: Englewood Hospital and Medical Center
the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.
This description comes directly from the study's public registry record.
Jamie Ketas · 2018943418 · jamie.ketas@ehmchealth.org
Raquel Molina · raquel.molina@ehmchealth.org
Always discuss trial participation with your own doctor first.
| Englewood Hospital | Englewood, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06681818